GCG and Parkinson disease: In addition, emerging experimental and clinical data implicate GLP-1 signaling in limiting PD pathologies (Harkavyi et al. 2008; Li et al. 2009; Aksoy et al. 2017; Athauda et al. 2017; Meissner et al. 2024).